Metered-Dose Inhaler Spacer with Integrated Spirometer for Home-Based Asthma Monitoring and Drug Uptake

Author:

Au Cheuk-Yan1ORCID,Koh Kelleen J. X.1,Lim Hui Fang2,Bhagat Ali Asgar Saleem13ORCID

Affiliation:

1. Institute for Health Innovation & Technology (iHealthtech), National University of Singapore (NUS) MD6, 14 Medical Drive, #14-01, Singapore 117599, Singapore

2. Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Health System, Singapore 119074, Singapore

3. Department of Biomedical Engineering, National University of Singapore (NUS), 4 Engineering Drive 3, Singapore 117583, Singapore

Abstract

This work introduces Spiromni, a single device incorporating three different pressurised metered-dose inhaler (pMDI) accessories: a pMDI spacer, an electronic monitoring device (EMD), and a spirometer. While there are devices made to individually address the issues of technique, adherence and monitoring, respectively, for asthma patients as laid out in the Global Initiative for Asthma’s (GINA) global strategy for asthma management and prevention, Spiromni was designed to address all three issues using a single, combination device. Spiromni addresses the key challenge of measuring both inhalation and exhalation profiles, which are different by an order of magnitude. Moreover, the innovative design prevents exhalation from entering the spacer chamber and prevents medication loss during inhalation using umbrella valves without a loss in flow velocity. Apart from recording the peak exhalation flow rate, data from the sensors allow us to extract other key lung volume and capacities measures similar to a medical pulmonary function test. We believe this low-cost portable multi-functional device will benefit both asthma patients and clinicians in the management of the disease.

Publisher

MDPI AG

Reference27 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019;Vos;Lancet,2020

2. Jeyagurunathan, A., Abdin, E., Shafie, S., Sambasivam, R., Yunjue, Z., Chua, B.Y., Vaingankar, J.A., Verma, S., Ee, T.W., and Chong, S.A. (2021). Focus: Health Equity: Asthma Prevalence and its Risk Factors Among a Multi-Ethnic Adult Population. Yale J. Biol. Med., 94.

3. National Health Service (NHS) (2023, September 27). Asthma—Overview. Available online: https://www.nhs.uk/conditions/asthma/.

4. National Health Service (NHS) (2023, September 27). Asthma—Asthma Attacks. Available online: https://www.nhs.uk/conditions/asthma/asthma-attack/.

5. Global strategy for asthma management and prevention: GINA executive summary;Bateman;Eur. Respir. J.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3